Cardiovascular risk factors and accelerated cognitive decline in midlife The CARDIA Study

被引:76
|
作者
Yaffe, Kristine [1 ,2 ,3 ,4 ]
Bahorik, Amber L. [1 ]
Hoang, Tina D. [5 ]
Forrester, Sarah [6 ]
Jacobs, David R., Jr. [7 ]
Lewis, Cora E. [8 ]
Lloyd-Jones, Donald M. [9 ]
Sidney, Stephen [10 ]
Reis, Jared P. [11 ]
机构
[1] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA
[4] San Francisco VA Med Ctr, San Francisco, CA 94121 USA
[5] Northern Calif Inst Res Res & Educ, San Francisco, CA USA
[6] Univ Massachusetts, Sch Med, Worcester, MA USA
[7] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA
[8] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA
[9] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[10] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[11] NHLBI, Bldg 10, Bethesda, MD 20892 USA
关键词
MIDDLE-AGED MEN; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; LIFE-COURSE; DEMENTIA; ASSOCIATION; LIPOPROTEINS; INFLAMMATION; PERFORMANCE; AMERICAN;
D O I
10.1212/WNL.0000000000010078
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective Increasing evidence supports an association between midlife cardiovascular risk factors (CVRFs) and risk of dementia, but less is known about whether CVRFs influence cognition in midlife. We examined the relationship between CVRFs and midlife cognitive decline. Methods In 2,675 black and white middle-aged adults (mean age 50.2 +/- 3.6 years, 57% female, 45% black), we measured CVRFs at baseline: hypertension (31%), diabetes mellitus (11%), obesity (43%), high cholesterol (9%), and current cigarette smoking (15%). We administered cognitive tests of memory, executive function, and processing speed at baseline and 5 years later. Using logistic regression, we estimated the association of CVRFs with accelerated cognitive decline (race-specific decline =1.5 SD from the mean change) on a composite cognitive score. Results Five percent (n = 143) of participants had accelerated cognitive decline over 5 years. Smoking, hypertension, and diabetes mellitus were associated with an increased likelihood of accelerated decline after multivariable adjustment (adjusted odds ratio [AOR] 1.65, 95% confidence interval [CI] 1.00-2.71; AOR 1.87, 95% CI 1.26-2.75; AOR 2.45, 95% CI 1.54-3.88, respectively), while obesity and high cholesterol were not associated with risk of decline. These results were similar when stratified by race. The likelihood of accelerated decline also increased with greater number of CVRFs (1-2 CVRFs: AOR 1.77, 95% CI 1.02-3.05; >= 3 CVRFs: AOR 2.94, 95% CI 1.64-5.28) and with Framingham Coronary Heart Disease Risk Score >= 10 (AOR 2.29, 95% CI 1.21-4.34). Conclusions Midlife CVRFs, especially hypertension, diabetes mellitus, and smoking, are common and associated with accelerated cognitive decline at midlife. These results identify potential modifiable targets to prevent midlife cognitive decline and highlight the need for a life course approach to cognitive function and aging.
引用
收藏
页码:E839 / E846
页数:8
相关论文
共 50 条
  • [1] Sex Differences in the Association Between Midlife Cardiovascular Conditions or Risk Factors With Midlife Cognitive Decline
    Huo, Nan
    Vemuri, Prashanthi
    Graff-Radford, Jonathan
    Syrjanen, Jeremy
    Machulda, Mary
    Knopman, David S.
    Jack, Clifford R., Jr.
    Petersen, Ronald
    Mielke, Michelle M.
    NEUROLOGY, 2022, 98 (06) : E623 - E632
  • [2] Midlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study results
    Gonzalez, Hector M.
    Tarraf, Wassim
    Harrison, Kimystian
    Windham, B. Gwen
    Tingle, Jonathan
    Alonso, Alvaro
    Griswold, Michael
    Heiss, Gerardo
    Knopman, David
    Mosley, Thomas H.
    ALZHEIMERS & DEMENTIA, 2018, 14 (05) : 579 - 589
  • [3] Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance The Young Finns Study
    Rovio, Suvi P.
    Pahkala, Katja
    Nevalainen, Jaakko
    Juonala, Markus
    Salo, Pia
    Kahonen, Mika
    Hutri-Kahonen, Nina
    Lehtimaki, Terho
    Jokinen, Eero
    Laitinen, Tomi
    Taittonen, Leena
    Tossavainen, Paivi
    Viikari, Jorma S. A.
    Rinne, Juha O.
    Raitakari, Olli T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (18) : 2279 - 2289
  • [4] Cardiovascular risk and midlife cognitive decline in the Study of Women's Health Across the Nation
    Derby, Carol A.
    Hutchins, Franya
    Greendale, Gail A.
    Matthews, Karen A.
    Sternfeld, Barbara
    Everson-Rose, Susan A.
    Kazlauskaite, Rasa
    Whitmer, Rachel A.
    Brooks, Maria M.
    ALZHEIMERS & DEMENTIA, 2021, 17 (08) : 1342 - 1352
  • [5] Midlife cardiovascular risk factors and late cognitive impairment
    Virta, Jyri J.
    Heikkila, Kauko
    Perola, Markus
    Koskenvuo, Markku
    Raiha, Ismo
    Rinne, Juha O.
    Kaprio, Jaakko
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2013, 28 (05) : 405 - 416
  • [6] Early Adult to Midlife Cardiovascular Risk Factors and Cognitive Function
    Yaffe, Kristine
    Vittinghoff, Eric
    Pletcher, Mark J.
    Hoang, Tina D.
    Launer, Lenore J.
    Whitmer, Rachel
    Coker, Laura H.
    Sidney, Stephen
    CIRCULATION, 2014, 129 (15) : 1560 - 1567
  • [7] Correlation between cardiovascular risk factors and cognitive decline
    Desideri, Giovambattista
    Bocale, Raffaella
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0E) : E73 - E76
  • [8] Midlife risk factors for late-life cognitive decline
    Carroll, Sarah
    Turkheimer, Eric
    DEVELOPMENTAL REVIEW, 2018, 48 : 201 - 222
  • [9] Premature Cardiovascular Disease and Brain Health in Midlife The CARDIA Study
    Jiang, Xiaqing
    Lewis, Cora E.
    Allen, Norrina B.
    Sidney, Stephen
    Yaffe, Kristine
    NEUROLOGY, 2023, 100 (14) : E1454 - E1463
  • [10] Cardiovascular Risk Factors Across the Life Course and Cognitive Decline A Pooled Cohort Study
    Yaffe, Kristine
    Vittinghoff, Eric
    Hoang, Tina
    Matthews, Karen
    Golden, Sherita H.
    Al Hazzouri, Adina Zeki
    NEUROLOGY, 2021, 96 (17) : E2212 - E2219